QT
EIGR

Quantbot Technologies’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Quantbot Technologies’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-77
Closed -$19K – 2014
2021
Q2 		$19K Buy
+77
New +$19.2K ﹤0.01% 1230
2015
Q2 		– Sell
-13
Closed -$114K – 1421
2015
Q1 		$114K Buy
+13
New +$114K 0.03% 569

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $88.2M AUM 25.13% 1-Year Est. Return

Quantbot Technologies's EIGR Position: Q3 2021 in Review

Quantbot Technologies sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q3 2021, closing a stake of 77 shares — an estimated $19K sold.

Quantbot Technologies first reported a position in EIGR in Q1 2015 and held it in 2 quarters. The position peaked at $114K in Q1 2015. 92 funds tracked by Wall St. Rank hold EIGR as of Q3 2021.

  • Quantbot Technologies reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Quantbot Technologies sold 77 Eiger BioPharmaceuticals, Inc. shares in Q3 2021, an estimated $19K.
  • Quantbot Technologies first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2015 and held it in 2 quarters.
  • Quantbot Technologies's Eiger BioPharmaceuticals, Inc. position peaked at $114K in Q1 2015.
  • 92 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q3 2021.

Based on Quantbot Technologies's 13F filing for Q3 2021, filed 9 Nov 2021.